data_1bpr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bpr _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.666 ' HG ' HD13 ' A' ' 382' ' ' ILE . 79.2 p . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 122.141 0.972 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.666 HD13 ' HG ' ' A' ' 381' ' ' SER . 1.9 mp 64.93 37.58 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -173.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 36.42 98.9 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 123.097 1.427 . . . . 0.0 114.802 -177.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -179.57 31.99 0.06 OUTLIER Glycine 0 CA--C 1.52 0.374 0 C-N-CA 118.622 -1.752 . . . . 0.0 110.154 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -97.67 61.46 1.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.23 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.01 -51.57 16.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.255 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.66 ' HZ1' ' H ' ' A' ' 507' ' ' LEU . 88.1 tttt -93.67 137.38 32.99 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.754 -0.779 . . . . 0.0 108.979 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -159.29 91.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 118.595 -1.242 . . . . 0.0 109.483 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 71.1 t -130.49 82.28 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 87.8 mt -136.8 -52.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 89.8 mt -114.3 25.43 11.09 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 66.5 mt -140.56 102.57 4.35 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -97.42 70.52 2.29 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 111.9 -2.409 . . . . 0.0 104.844 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.47 HG23 ' H ' ' A' ' 415' ' ' ASN . 35.0 m -126.97 -173.26 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.676 -170.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' THR . . . . . . . . . . . . . 62.8 p -62.2 116.62 23.35 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -90.64 13.21 2.25 Favored 'Trans proline' 0 C--N 1.347 0.461 0 CA-C-N 122.586 1.959 . . . . 0.0 115.232 -139.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' LEU . . . . . 0.436 ' H ' ' H ' ' A' ' 398' ' ' SER . 0.4 OUTLIER -163.24 -9.22 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 117.616 -1.634 . . . . 0.0 109.558 -177.236 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' SER . . . . . 0.509 ' HG ' ' H ' ' A' ' 414' ' ' LYS . 1.2 m 82.48 125.69 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.98 113.43 4.96 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -171.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 440' ' ' VAL . . . -135.7 -105.17 0.79 Allowed Glycine 0 CA--C 1.475 -2.407 0 CA-C-O 119.038 -0.868 . . . . 0.0 114.363 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . . . . . . . . . 6.6 mm -140.29 149.52 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 119.681 1.74 . . . . 0.0 109.112 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -65.65 126.25 27.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 172.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' THR . . . . . . . . . . . . . 2.6 p -114.21 177.71 4.54 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.62 1.2 . . . . 0.0 113.808 -172.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 65.6 mtt -43.97 93.42 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 119.103 3.001 . . . . 0.0 119.103 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 103.24 32.26 4.68 Favored Glycine 0 N--CA 1.471 0.992 0 C-N-CA 120.095 -1.05 . . . . 0.0 114.733 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 74.05 47.13 19.65 Favored Glycine 0 C--N 1.319 -0.412 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.5 t -121.86 163.84 19.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -131.75 128.8 39.62 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.523 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' THR . . . . . . . . . . . . . 28.4 m -122.71 126.47 47.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 1.8 t -77.61 158.14 29.93 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.342 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' LEU . . . . . . . . . . . . . 5.9 mt -101.54 -55.43 2.53 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 -175.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.3 tt -119.47 137.87 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 111.752 -2.476 . . . . 0.0 105.106 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -111.0 168.8 9.22 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.98 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.509 ' H ' ' HG ' ' A' ' 398' ' ' SER . 55.3 pttt -60.84 156.22 17.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.546 -1.206 . . . . 0.0 107.997 174.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ASN . . . . . 0.47 ' H ' HG23 ' A' ' 394' ' ' VAL . 49.1 t30 93.87 -9.67 0.14 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -171.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 1.4 m -99.08 114.33 26.99 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 27.3 p -87.28 136.49 32.91 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.755 -1.566 . . . . 0.0 112.313 -170.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . . . . . . . . . 17.8 pt -83.62 129.33 60.21 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 118.467 -1.293 . . . . 0.0 108.632 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -91.32 136.4 9.29 Favored 'Cis proline' 0 C--N 1.345 0.367 0 C-N-CA 123.078 -1.634 . . . . 0.0 110.434 18.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' THR . . . . . 0.611 ' H ' HG21 ' A' ' 478' ' ' ILE . 29.1 p -107.67 166.55 10.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.695 1.236 . . . . 0.0 109.683 -175.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -157.31 120.1 3.96 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.048 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -159.67 142.73 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 118.072 -1.451 . . . . 0.0 110.247 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 47.4 t -113.73 130.76 56.38 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.617 -174.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -135.69 120.07 17.98 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 2.5 p -94.44 135.08 29.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.077 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -131.46 171.13 13.76 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 123.37 1.557 . . . . 0.0 111.795 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 57.8 p -146.36 -171.15 3.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.191 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.5 p -126.43 165.0 19.89 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 119.136 -1.025 . . . . 0.0 109.829 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -92.04 -17.78 24.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.806 0.812 . . . . 0.0 109.303 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -148.71 134.8 19.2 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 56.8 91.99 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.851 0.834 . . . . 0.0 109.371 -174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -83.81 -68.61 0.7 Allowed 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.984 -173.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -97.26 71.39 2.38 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' SER . . . . . 0.566 ' HA ' ' H ' ' A' ' 462' ' ' ILE . 1.9 t -159.32 -24.25 0.07 Allowed 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.217 -1.393 . . . . 0.0 110.011 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -167.29 114.68 0.78 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 117.963 -1.495 . . . . 0.0 111.989 172.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.92 142.43 17.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 102.099 -3.297 . . . . 0.0 102.099 171.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 13.9 m -95.06 127.84 41.43 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.261 -1.376 . . . . 0.0 108.287 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 25.6 mm -106.91 53.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 122.841 1.305 . . . . 0.0 107.667 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -92.76 95.8 9.77 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 102.098 -3.297 . . . . 0.0 102.098 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 400' ' ' GLY . 1.5 t -85.4 130.02 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 -171.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.6 tp -110.98 110.51 21.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 123.091 1.425 . . . . 0.0 113.463 -172.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . 1.352 ' O ' ' HB3' ' A' ' 452' ' ' LYS . 62.8 tt0 -90.13 99.51 12.52 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 112.622 -2.081 . . . . 0.0 110.475 174.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -156.49 -134.48 1.8 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 119.125 -1.512 . . . . 0.0 110.567 174.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -103.48 -86.6 0.44 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.828 -0.807 . . . . 0.0 111.367 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -158.38 -103.85 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 117.986 -1.486 . . . . 0.0 113.235 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.28 -50.31 8.52 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 119.926 -1.733 . . . . 0.0 113.194 -172.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.01 108.49 2.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -83.06 86.92 6.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 123.743 1.735 . . . . 0.0 115.297 -172.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 512' ' ' ILE . . . -128.11 24.44 5.97 Favored 'General case' 0 CA--C 1.515 -0.381 1 N-CA-C 96.84 -5.244 . . . . 0.0 96.84 169.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . 0.266 48.3 m-20 -99.4 40.94 1.18 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 110.338 -3.119 . . . . 0.0 109.378 -173.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -101.05 50.28 0.87 Allowed 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.499 -1.28 . . . . 0.0 112.069 -172.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' LYS . . . . . 1.352 ' HB3' ' O ' ' A' ' 442' ' ' GLN . 59.1 tptt -75.47 128.98 36.53 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 50.4 m -73.05 124.39 25.42 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.33 -1.348 . . . . 0.0 111.831 -172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.401 ' O ' ' HB ' ' A' ' 440' ' ' VAL . 0.3 OUTLIER -131.52 32.13 4.21 Favored 'General case' 0 N--CA 1.442 -0.858 1 N-CA-C 98.68 -4.563 . . . . 0.0 98.68 172.59 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . 130.59 178.78 15.62 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 118.011 -2.042 . . . . 0.0 117.407 172.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -175.41 77.19 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 112.645 -1.778 . . . . 0.0 106.399 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -135.63 -171.94 2.97 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -153.81 132.34 12.13 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.198 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 5.6 tt -86.98 101.61 13.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -112.46 152.63 28.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.725 1.25 . . . . 0.0 113.409 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 81.52 69.78 1.38 Allowed Glycine 0 C--N 1.324 -0.123 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.391 174.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . 0.566 ' H ' ' HA ' ' A' ' 434' ' ' SER . 2.3 mp -119.57 56.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 118.18 -1.408 . . . . 0.0 107.975 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 10.3 m120 64.33 162.44 0.12 Allowed Pre-proline 0 CA--C 1.558 1.276 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.39 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -85.18 105.12 0.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 O-C-N 118.086 -1.586 . . . . 0.0 110.099 -173.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -152.9 82.3 5.01 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 119.033 -1.067 . . . . 0.0 108.162 174.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -95.56 154.31 1.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 CA-C-N 121.341 1.515 . . . . 0.0 110.924 -159.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 58.3 106.48 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 69.61 133.87 0.07 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 119.596 -1.288 . . . . 0.0 114.154 173.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 54.6 mmm -138.94 -61.19 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 116.632 -1.651 . . . . 0.0 109.823 173.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -113.08 86.84 0.03 OUTLIER 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 126.257 3.27 . . . . 0.0 108.081 -5.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' GLN . . . . . 0.897 ' O ' ' HB2' ' A' ' 491' ' ' LYS . 90.1 mt-30 -130.31 59.13 1.65 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -172.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' ILE . . . . . . . . . . . . . 2.1 mt -117.17 98.59 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -81.97 132.61 35.26 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 118.733 -1.187 . . . . 0.0 108.921 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 57.4 t -120.79 114.36 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -174.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 138.48 48.17 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.007 -175.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -130.52 108.61 10.07 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.614 1.197 . . . . 0.0 108.191 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -111.46 121.07 44.23 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.991 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . 0.611 HG21 ' H ' ' A' ' 420' ' ' THR . 9.2 tt -95.2 152.94 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 117.037 -1.865 . . . . 0.0 106.1 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.98 -177.2 4.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -84.6 -17.53 38.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.98 -174.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -84.27 -36.56 22.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.064 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 125.84 71.61 0.19 Allowed Glycine 0 N--CA 1.467 0.719 0 C-N-CA 119.634 -1.269 . . . . 0.0 110.859 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 4.7 tp -149.72 128.75 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 14.8 tp -84.45 102.37 12.75 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 118.653 -1.219 . . . . 0.0 107.924 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -87.1 83.45 7.45 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.91 -1.496 . . . . 0.0 108.559 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.49 124.94 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 122.312 1.053 . . . . 0.0 109.7 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 68.6 p -110.08 108.57 18.81 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.795 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 496' ' ' GLU . . . -76.86 104.96 7.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 173.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -101.82 124.03 46.76 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.21 146.73 27.13 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -174.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.897 ' HB2' ' O ' ' A' ' 471' ' ' GLN . 3.5 mmpt? -102.35 40.56 1.33 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.998 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -102.47 -43.39 5.66 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' SER . . . . . . . . . . . . . 70.9 m -155.4 13.77 0.37 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 118.626 -1.23 . . . . 0.0 107.883 173.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . 80.59 34.08 29.31 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.07 101.0 5.13 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 488' ' ' ALA . 9.4 pt-20 -122.92 162.76 21.63 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 118.719 -1.193 . . . . 0.0 112.242 -173.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -142.56 117.1 9.71 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -99.59 105.21 17.05 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.202 -176.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 5.2 pt -89.73 154.52 3.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 122.753 1.263 . . . . 0.0 108.883 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.9 p -128.31 85.97 2.4 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.7 tt -110.87 140.82 28.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.051 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 66.2 mttp -64.78 175.1 1.57 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.717 1.246 . . . . 0.0 111.858 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -164.14 33.82 0.08 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.618 -1.174 . . . . 0.0 107.841 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 46.5 t -70.51 144.52 51.33 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.956 -174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 98.0 p -81.04 -143.43 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.772 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 91.02 54.29 2.05 Favored Glycine 0 N--CA 1.463 0.457 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.193 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' LEU . . . . . 0.66 ' H ' ' HZ1' ' A' ' 387' ' ' LYS . 0.6 OUTLIER -156.74 -162.27 1.22 Allowed 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.567 175.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' ASN . . . . . 0.576 ' O ' ' HB3' ' A' ' 511' ' ' GLU . 84.0 m-20 -131.4 165.63 23.06 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 123.395 1.569 . . . . 0.0 113.427 -173.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.64 -21.42 62.63 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 113.619 -1.628 . . . . 0.0 111.087 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' ASP . . . . . 0.955 ' O ' ' HB2' ' A' ' 514' ' ' LYS . 5.2 p-10 -112.14 34.84 4.03 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 123.696 1.712 . . . . 0.0 107.599 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.576 ' HB3' ' O ' ' A' ' 508' ' ' ASN . 9.5 tp10 -94.74 -39.97 10.02 Favored 'General case' 0 N--CA 1.435 -1.187 1 N-CA-C 92.415 -6.883 . . . . 0.0 92.415 166.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 449' ' ' ALA . 2.4 mp -71.01 -66.7 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.355 0 CA-C-N 112.294 -2.23 . . . . 0.0 108.829 172.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' GLN . . . . . 0.485 ' N ' ' HA ' ' A' ' 510' ' ' ASP . 43.7 tt0 -60.88 -20.27 61.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 118.246 -2.784 . . . . 0.0 115.5 176.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' LYS . . . . . 0.955 ' HB2' ' O ' ' A' ' 510' ' ' ASP . 88.6 tttt -76.37 -27.6 56.45 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 119.165 -2.209 . . . . 0.0 106.633 173.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' MET . . . . . . . . . . . . . 25.5 mtm -84.4 -3.78 58.52 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.386 172.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' VAL . . . . . 0.866 ' HA ' ' HB2' ' A' ' 520' ' ' GLU . 1.7 t -75.51 -35.69 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 171.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -71.28 -72.81 0.2 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 115.089 -2.644 . . . . 0.0 110.706 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -57.53 -50.22 73.81 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 118.904 -1.118 . . . . 0.0 110.344 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' ALA . . . . . . . . . . . . . . . -99.45 -6.69 27.21 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 118.175 -1.41 . . . . 0.0 113.283 -171.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.866 ' HB2' ' HA ' ' A' ' 516' ' ' VAL . 22.3 tt0 -84.94 -31.07 23.81 Favored 'General case' 0 C--N 1.366 1.302 1 N-CA-C 99.873 -4.121 . . . . 0.0 99.873 -177.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.96 -29.99 66.15 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.119 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -74.66 -10.45 59.55 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 120.609 -1.307 . . . . 0.0 111.422 174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -69.45 -6.36 29.81 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 120.446 -1.409 . . . . 0.0 111.883 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 527' ' ' ARG . 35.4 tt0 -75.65 -26.98 58.17 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.612 -1.305 . . . . 0.0 108.353 173.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -72.96 -32.13 65.03 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -71.83 -12.56 61.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 118.837 -1.145 . . . . 0.0 109.758 172.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.512 ' HB3' ' O ' ' A' ' 524' ' ' GLU . 79.7 ttt180 -71.66 -30.21 65.47 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.237 1.018 . . . . 0.0 108.578 173.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -67.18 -36.32 81.52 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -78.73 -3.98 46.98 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 118.837 -1.145 . . . . 0.0 111.567 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.39 -19.47 28.06 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -76.94 -32.4 57.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 13.6 tp -69.92 -32.63 71.02 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.644 174.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' VAL . . . . . . . . . . . . . 41.1 t -63.89 -54.77 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' GLN . . . . . 0.469 ' H ' ' H ' ' A' ' 535' ' ' THR . 22.9 tt0 119.44 9.29 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.469 ' H ' ' H ' ' A' ' 534' ' ' GLN . 0.9 OUTLIER 54.74 113.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 111.751 -2.477 . . . . 0.0 114.617 174.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' ARG . . . . . . . . . . . . . 6.6 ptm85 -160.36 -104.63 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.417 -1.719 . . . . 0.0 106.814 -175.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' ASN . . . . . . . . . . . . 0.252 0.1 OUTLIER 140.18 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 O-C-N 125.299 1.625 . . . . 0.0 109.463 173.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 69.69 -95.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.716 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 84.8 38.24 9.64 Favored Glycine 0 C--N 1.318 -0.451 0 C-N-CA 118.642 -1.742 . . . . 0.0 111.502 174.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -73.71 112.52 9.89 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 78.48 -64.33 0.27 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 124.22 0.95 . . . . 0.0 111.636 -174.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.03 146.1 53.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.491 -0.883 . . . . 0.0 109.312 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 2.5 tt -169.09 102.56 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -174.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -62.25 143.32 57.01 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.69 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 15.1 p -160.09 108.91 1.73 Allowed 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.828 -174.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 9.0 t -159.71 139.81 11.76 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 118.435 -1.306 . . . . 0.0 109.728 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -83.54 -175.28 5.74 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.144 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -159.87 112.1 2.07 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.05 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -162.14 74.98 0.44 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.637 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.33 169.6 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.149 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.3 -17.75 33.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.898 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.478 ' O ' ' HB1' ' A' ' 553' ' ' ALA . 51.8 mt-10 -81.62 157.77 24.58 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.898 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' ALA . . . . . 0.478 ' HB1' ' O ' ' A' ' 552' ' ' GLU . . . . . . . . 0 C--O 1.27 2.155 0 CA-C-N 120.581 1.537 . . . . 0.0 110.98 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 122.141 0.972 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 1.9 mp 64.93 37.58 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -173.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 36.42 98.9 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 123.097 1.427 . . . . 0.0 114.802 -177.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -179.57 31.99 0.06 OUTLIER Glycine 0 CA--C 1.52 0.374 0 C-N-CA 118.622 -1.752 . . . . 0.0 110.154 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -97.67 61.46 1.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.23 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.01 -51.57 16.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.255 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -93.67 137.38 32.99 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.754 -0.779 . . . . 0.0 108.979 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -159.29 91.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 118.595 -1.242 . . . . 0.0 109.483 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 71.1 t -130.49 82.28 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 87.8 mt -136.8 -52.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 89.8 mt -114.3 25.43 11.09 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 66.5 mt -140.56 102.57 4.35 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -97.42 70.52 2.29 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 111.9 -2.409 . . . . 0.0 104.844 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.439 HG21 ' H ' ' A' ' 415' ' ' ASN . 35.0 m -126.97 -173.26 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.676 -170.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' THR . . . . . . . . . . . . . 62.8 p -62.2 116.62 23.35 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -90.64 13.21 2.25 Favored 'Trans proline' 0 C--N 1.347 0.461 0 CA-C-N 122.586 1.959 . . . . 0.0 115.232 -139.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' LEU . . . . . 0.436 ' H ' ' H ' ' A' ' 398' ' ' SER . 0.4 OUTLIER -163.24 -9.22 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 117.616 -1.634 . . . . 0.0 109.558 -177.236 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 398' ' ' SER . . . . . 0.436 ' H ' ' H ' ' A' ' 397' ' ' LEU . 1.2 m 82.48 125.69 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.98 113.43 4.96 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -171.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 440' ' ' VAL . . . -135.7 -105.17 0.79 Allowed Glycine 0 CA--C 1.475 -2.407 0 CA-C-O 119.038 -0.868 . . . . 0.0 114.363 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 400' ' ' GLY . 6.6 mm -140.29 149.52 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 119.681 1.74 . . . . 0.0 109.112 -173.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -65.65 126.25 27.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 172.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' THR . . . . . . . . . . . . . 2.6 p -114.21 177.71 4.54 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.62 1.2 . . . . 0.0 113.808 -172.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 65.6 mtt -43.97 93.42 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 119.103 3.001 . . . . 0.0 119.103 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.443 ' H ' HG21 ' A' ' 533' ' ' VAL . . . 103.24 32.26 4.68 Favored Glycine 0 N--CA 1.471 0.992 0 C-N-CA 120.095 -1.05 . . . . 0.0 114.733 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 74.05 47.13 19.65 Favored Glycine 0 C--N 1.319 -0.412 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.5 t -121.86 163.84 19.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -131.75 128.8 39.62 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.523 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' THR . . . . . . . . . . . . . 28.4 m -122.71 126.47 47.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 1.8 t -77.61 158.14 29.93 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.342 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' LEU . . . . . . . . . . . . . 5.9 mt -101.54 -55.43 2.53 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 -175.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.3 tt -119.47 137.87 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 111.752 -2.476 . . . . 0.0 105.106 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -111.0 168.8 9.22 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.98 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -60.84 156.22 17.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.546 -1.206 . . . . 0.0 107.997 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ASN . . . . . 0.439 ' H ' HG21 ' A' ' 394' ' ' VAL . 49.1 t30 93.87 -9.67 0.14 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -171.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 1.4 m -99.08 114.33 26.99 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 27.3 p -87.28 136.49 32.91 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.755 -1.566 . . . . 0.0 112.313 -170.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.453 HG22 HG21 ' A' ' 478' ' ' ILE . 17.8 pt -83.62 129.33 60.21 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 118.467 -1.293 . . . . 0.0 108.632 -174.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -91.32 136.4 9.29 Favored 'Cis proline' 0 C--N 1.345 0.367 0 C-N-CA 123.078 -1.634 . . . . 0.0 110.434 18.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' THR . . . . . 0.531 ' H ' HG22 ' A' ' 478' ' ' ILE . 29.1 p -107.67 166.55 10.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.695 1.236 . . . . 0.0 109.683 -175.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -157.31 120.1 3.96 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.048 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -159.67 142.73 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 118.072 -1.451 . . . . 0.0 110.247 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 47.4 t -113.73 130.76 56.38 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.617 -174.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -135.69 120.07 17.98 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 2.5 p -94.44 135.08 29.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.077 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -131.46 171.13 13.76 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 123.37 1.557 . . . . 0.0 111.795 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 57.8 p -146.36 -171.15 3.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.191 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.5 p -126.43 165.0 19.89 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 119.136 -1.025 . . . . 0.0 109.829 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -92.04 -17.78 24.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.806 0.812 . . . . 0.0 109.303 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -148.71 134.8 19.2 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 56.8 91.99 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.851 0.834 . . . . 0.0 109.371 -174.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ASN . . . . . 0.445 ' H ' ' HA ' ' A' ' 466' ' ' PRO . 21.2 t-20 -83.81 -68.61 0.7 Allowed 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.984 -173.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -97.26 71.39 2.38 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' SER . . . . . 0.545 ' HA ' ' H ' ' A' ' 462' ' ' ILE . 1.9 t -159.32 -24.25 0.07 Allowed 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.217 -1.393 . . . . 0.0 110.011 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -167.29 114.68 0.78 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 117.963 -1.495 . . . . 0.0 111.989 172.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.92 142.43 17.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 102.099 -3.297 . . . . 0.0 102.099 171.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 13.9 m -95.06 127.84 41.43 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.261 -1.376 . . . . 0.0 108.287 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 25.6 mm -106.91 53.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 122.841 1.305 . . . . 0.0 107.667 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -92.76 95.8 9.77 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 102.098 -3.297 . . . . 0.0 102.098 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 400' ' ' GLY . 1.5 t -85.4 130.02 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 -171.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.6 tp -110.98 110.51 21.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 123.091 1.425 . . . . 0.0 113.463 -172.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' GLN . . . . . 1.329 ' O ' ' HB3' ' A' ' 452' ' ' LYS . 62.8 tt0 -90.13 99.51 12.52 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 112.622 -2.081 . . . . 0.0 110.475 174.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -156.49 -134.48 1.8 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 119.125 -1.512 . . . . 0.0 110.567 174.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -103.48 -86.6 0.44 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.828 -0.807 . . . . 0.0 111.367 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -158.38 -103.85 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 117.986 -1.486 . . . . 0.0 113.235 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.28 -50.31 8.52 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 119.926 -1.733 . . . . 0.0 113.194 -172.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.01 108.49 2.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -83.06 86.92 6.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 123.743 1.735 . . . . 0.0 115.297 -172.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -128.11 24.44 5.97 Favored 'General case' 0 CA--C 1.515 -0.381 1 N-CA-C 96.84 -5.244 . . . . 0.0 96.84 169.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . 0.266 48.3 m-20 -99.4 40.94 1.18 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 110.338 -3.119 . . . . 0.0 109.378 -173.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -101.05 50.28 0.87 Allowed 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.499 -1.28 . . . . 0.0 112.069 -172.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' LYS . . . . . 1.329 ' HB3' ' O ' ' A' ' 442' ' ' GLN . 59.1 tptt -75.47 128.98 36.53 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 50.4 m -73.05 124.39 25.42 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.33 -1.348 . . . . 0.0 111.831 -172.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.52 32.13 4.21 Favored 'General case' 0 N--CA 1.442 -0.858 1 N-CA-C 98.68 -4.563 . . . . 0.0 98.68 172.59 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . 130.59 178.78 15.62 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 118.011 -2.042 . . . . 0.0 117.407 172.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -175.41 77.19 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 112.645 -1.778 . . . . 0.0 106.399 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -135.63 -171.94 2.97 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -153.81 132.34 12.13 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.198 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 5.6 tt -86.98 101.61 13.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -112.46 152.63 28.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.725 1.25 . . . . 0.0 113.409 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 81.52 69.78 1.38 Allowed Glycine 0 C--N 1.324 -0.123 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.391 174.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' ILE . . . . . 0.545 ' H ' ' HA ' ' A' ' 434' ' ' SER . 2.3 mp -119.57 56.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 118.18 -1.408 . . . . 0.0 107.975 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 10.3 m120 64.33 162.44 0.12 Allowed Pre-proline 0 CA--C 1.558 1.276 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.39 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -85.18 105.12 0.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 O-C-N 118.086 -1.586 . . . . 0.0 110.099 -173.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -152.9 82.3 5.01 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 119.033 -1.067 . . . . 0.0 108.162 174.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.445 ' HA ' ' H ' ' A' ' 432' ' ' ASN . 47.0 Cg_endo -95.56 154.31 1.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 CA-C-N 121.341 1.515 . . . . 0.0 110.924 -159.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 58.3 106.48 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 69.61 133.87 0.07 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 119.596 -1.288 . . . . 0.0 114.154 173.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 54.6 mmm -138.94 -61.19 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 116.632 -1.651 . . . . 0.0 109.823 173.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -113.08 86.84 0.03 OUTLIER 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 126.257 3.27 . . . . 0.0 108.081 -5.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' GLN . . . . . 0.891 ' O ' ' HB2' ' A' ' 491' ' ' LYS . 90.1 mt-30 -130.31 59.13 1.65 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -172.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 472' ' ' ILE . . . . . 0.413 HG23 ' HA ' ' A' ' 490' ' ' ASP . 2.1 mt -117.17 98.59 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -81.97 132.61 35.26 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 118.733 -1.187 . . . . 0.0 108.921 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 57.4 t -120.79 114.36 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -174.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 138.48 48.17 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.007 -175.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 476' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -130.52 108.61 10.07 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.614 1.197 . . . . 0.0 108.191 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -111.46 121.07 44.23 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.991 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 420' ' ' THR . 9.2 tt -95.2 152.94 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 117.037 -1.865 . . . . 0.0 106.1 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.98 -177.2 4.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -84.6 -17.53 38.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.98 -174.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -84.27 -36.56 22.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.064 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 125.84 71.61 0.19 Allowed Glycine 0 N--CA 1.467 0.719 0 C-N-CA 119.634 -1.269 . . . . 0.0 110.859 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 4.7 tp -149.72 128.75 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 14.8 tp -84.45 102.37 12.75 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 118.653 -1.219 . . . . 0.0 107.924 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -87.1 83.45 7.45 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.91 -1.496 . . . . 0.0 108.559 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.49 124.94 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 122.312 1.053 . . . . 0.0 109.7 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 68.6 p -110.08 108.57 18.81 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.795 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 496' ' ' GLU . . . -76.86 104.96 7.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 173.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 489' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -101.82 124.03 46.76 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' ASP . . . . . 0.413 ' HA ' HG23 ' A' ' 472' ' ' ILE . 0.8 OUTLIER -101.21 146.73 27.13 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -174.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.891 ' HB2' ' O ' ' A' ' 471' ' ' GLN . 3.5 mmpt? -102.35 40.56 1.33 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.998 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -102.47 -43.39 5.66 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' SER . . . . . . . . . . . . . 70.9 m -155.4 13.77 0.37 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 118.626 -1.23 . . . . 0.0 107.883 173.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . 80.59 34.08 29.31 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.07 101.0 5.13 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 488' ' ' ALA . 9.4 pt-20 -122.92 162.76 21.63 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 118.719 -1.193 . . . . 0.0 112.242 -173.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 497' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -142.56 117.1 9.71 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 498' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -99.59 105.21 17.05 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.202 -176.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 5.2 pt -89.73 154.52 3.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 122.753 1.263 . . . . 0.0 108.883 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.9 p -128.31 85.97 2.4 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.7 tt -110.87 140.82 28.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.051 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 66.2 mttp -64.78 175.1 1.57 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.717 1.246 . . . . 0.0 111.858 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -164.14 33.82 0.08 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.618 -1.174 . . . . 0.0 107.841 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 46.5 t -70.51 144.52 51.33 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.956 -174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 98.0 p -81.04 -143.43 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.772 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 91.02 54.29 2.05 Favored Glycine 0 N--CA 1.463 0.457 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.193 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.74 -162.27 1.22 Allowed 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.567 175.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 508' ' ' ASN . . . . . 0.567 ' O ' ' HB3' ' A' ' 511' ' ' GLU . 84.0 m-20 -131.4 165.63 23.06 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 123.395 1.569 . . . . 0.0 113.427 -173.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.64 -21.42 62.63 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 113.619 -1.628 . . . . 0.0 111.087 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' ASP . . . . . 0.946 ' O ' ' HB2' ' A' ' 514' ' ' LYS . 5.2 p-10 -112.14 34.84 4.03 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 123.696 1.712 . . . . 0.0 107.599 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 508' ' ' ASN . 9.5 tp10 -94.74 -39.97 10.02 Favored 'General case' 0 N--CA 1.435 -1.187 1 N-CA-C 92.415 -6.883 . . . . 0.0 92.415 166.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.01 -66.7 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.355 0 CA-C-N 112.294 -2.23 . . . . 0.0 108.829 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' GLN . . . . . 0.429 ' C ' ' H ' ' A' ' 516' ' ' VAL . 43.7 tt0 -60.88 -20.27 61.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 118.246 -2.784 . . . . 0.0 115.5 176.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 514' ' ' LYS . . . . . 0.946 ' HB2' ' O ' ' A' ' 510' ' ' ASP . 88.6 tttt -76.37 -27.6 56.45 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 119.165 -2.209 . . . . 0.0 106.633 173.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 515' ' ' MET . . . . . 0.402 ' HB3' ' HB3' ' A' ' 519' ' ' ALA . 25.5 mtm -84.4 -3.78 58.52 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.386 172.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 516' ' ' VAL . . . . . 0.858 ' HA ' ' HB2' ' A' ' 520' ' ' GLU . 1.7 t -75.51 -35.69 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 171.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -71.28 -72.81 0.2 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 115.089 -2.644 . . . . 0.0 110.706 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -57.53 -50.22 73.81 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 118.904 -1.118 . . . . 0.0 110.344 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 515' ' ' MET . . . -99.45 -6.69 27.21 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 118.175 -1.41 . . . . 0.0 113.283 -171.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.858 ' HB2' ' HA ' ' A' ' 516' ' ' VAL . 22.3 tt0 -84.94 -31.07 23.81 Favored 'General case' 0 C--N 1.366 1.302 1 N-CA-C 99.873 -4.121 . . . . 0.0 99.873 -177.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.96 -29.99 66.15 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.119 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -74.66 -10.45 59.55 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 120.609 -1.307 . . . . 0.0 111.422 174.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -69.45 -6.36 29.81 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 120.446 -1.409 . . . . 0.0 111.883 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 524' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 527' ' ' ARG . 35.4 tt0 -75.65 -26.98 58.17 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.612 -1.305 . . . . 0.0 108.353 173.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -72.96 -32.13 65.03 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -71.83 -12.56 61.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 118.837 -1.145 . . . . 0.0 109.758 172.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 524' ' ' GLU . 79.7 ttt180 -71.66 -30.21 65.47 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.237 1.018 . . . . 0.0 108.578 173.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 528' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -67.18 -36.32 81.52 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' PHE . . . . . 0.536 ' O ' HG23 ' A' ' 533' ' ' VAL . 73.0 m-85 -78.73 -3.98 46.98 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 118.837 -1.145 . . . . 0.0 111.567 173.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 530' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.39 -19.47 28.06 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -76.94 -32.4 57.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 13.6 tp -69.92 -32.63 71.02 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.644 174.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 529' ' ' PHE . 41.1 t -63.89 -54.77 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 534' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 119.44 9.29 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 54.74 113.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 111.751 -2.477 . . . . 0.0 114.617 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 536' ' ' ARG . . . . . . . . . . . . . 6.6 ptm85 -160.36 -104.63 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.417 -1.719 . . . . 0.0 106.814 -175.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' ASN . . . . . . . . . . . . 0.252 13.3 p-10 140.18 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 O-C-N 125.299 1.625 . . . . 0.0 109.463 173.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 538' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 69.69 -95.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.716 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 84.8 38.24 9.64 Favored Glycine 0 C--N 1.318 -0.451 0 C-N-CA 118.642 -1.742 . . . . 0.0 111.502 174.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -73.71 112.52 9.89 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 78.48 -64.33 0.27 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 124.22 0.95 . . . . 0.0 111.636 -174.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.03 146.1 53.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.491 -0.883 . . . . 0.0 109.312 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 2.5 tt -169.09 102.56 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -174.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -62.25 143.32 57.01 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.69 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 15.1 p -160.09 108.91 1.73 Allowed 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.828 -174.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 9.0 t -159.71 139.81 11.76 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 118.435 -1.306 . . . . 0.0 109.728 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -83.54 -175.28 5.74 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.144 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 548' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -159.87 112.1 2.07 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.05 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 549' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -162.14 74.98 0.44 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.637 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.33 169.6 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.149 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.3 -17.75 33.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.898 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 553' ' ' ALA . 51.8 mt-10 -81.62 157.77 24.58 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.898 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 553' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 552' ' ' GLU . . . . . . . . 0 C--O 1.27 2.155 0 CA-C-N 120.581 1.537 . . . . 0.0 110.98 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 122.141 0.972 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . . . . . . . . . 1.9 mp 64.93 37.58 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -173.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 36.42 98.9 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 123.097 1.427 . . . . 0.0 114.802 -177.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -179.57 31.99 0.06 OUTLIER Glycine 0 CA--C 1.52 0.374 0 C-N-CA 118.622 -1.752 . . . . 0.0 110.154 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -97.67 61.46 1.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.23 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.01 -51.57 16.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.255 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -93.67 137.38 32.99 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.754 -0.779 . . . . 0.0 108.979 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -159.29 91.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 118.595 -1.242 . . . . 0.0 109.483 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 71.1 t -130.49 82.28 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 87.8 mt -136.8 -52.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 89.8 mt -114.3 25.43 11.09 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 66.5 mt -140.56 102.57 4.35 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -97.42 70.52 2.29 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 111.9 -2.409 . . . . 0.0 104.844 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.439 HG21 ' H ' ' A' ' 415' ' ' ASN . 35.0 m -126.97 -173.26 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.676 -170.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' THR . . . . . . . . . . . . . 62.8 p -62.2 116.62 23.35 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -90.64 13.21 2.25 Favored 'Trans proline' 0 C--N 1.347 0.461 0 CA-C-N 122.586 1.959 . . . . 0.0 115.232 -139.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' LEU . . . . . 0.436 ' H ' ' H ' ' A' ' 398' ' ' SER . 0.4 OUTLIER -163.24 -9.22 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 117.616 -1.634 . . . . 0.0 109.558 -177.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . 0.436 ' H ' ' H ' ' A' ' 397' ' ' LEU . 1.2 m 82.48 125.69 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.98 113.43 4.96 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -171.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 440' ' ' VAL . . . -135.7 -105.17 0.79 Allowed Glycine 0 CA--C 1.475 -2.407 0 CA-C-O 119.038 -0.868 . . . . 0.0 114.363 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 400' ' ' GLY . 6.6 mm -140.29 149.52 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 119.681 1.74 . . . . 0.0 109.112 -173.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -65.65 126.25 27.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 172.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' THR . . . . . . . . . . . . . 2.6 p -114.21 177.71 4.54 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.62 1.2 . . . . 0.0 113.808 -172.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' MET . . . . . . . . . . . . . 65.6 mtt -43.97 93.42 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 119.103 3.001 . . . . 0.0 119.103 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.443 ' H ' HG21 ' A' ' 533' ' ' VAL . . . 103.24 32.26 4.68 Favored Glycine 0 N--CA 1.471 0.992 0 C-N-CA 120.095 -1.05 . . . . 0.0 114.733 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 74.05 47.13 19.65 Favored Glycine 0 C--N 1.319 -0.412 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 6.5 t -121.86 163.84 19.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -131.75 128.8 39.62 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.523 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' THR . . . . . . . . . . . . . 28.4 m -122.71 126.47 47.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 1.8 t -77.61 158.14 29.93 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.342 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' LEU . . . . . . . . . . . . . 5.9 mt -101.54 -55.43 2.53 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 -175.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.3 tt -119.47 137.87 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 111.752 -2.476 . . . . 0.0 105.106 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -111.0 168.8 9.22 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.98 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -60.84 156.22 17.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.546 -1.206 . . . . 0.0 107.997 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ASN . . . . . 0.439 ' H ' HG21 ' A' ' 394' ' ' VAL . 49.1 t30 93.87 -9.67 0.14 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -171.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 1.4 m -99.08 114.33 26.99 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 173.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 27.3 p -87.28 136.49 32.91 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.755 -1.566 . . . . 0.0 112.313 -170.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.453 HG22 HG21 ' A' ' 478' ' ' ILE . 17.8 pt -83.62 129.33 60.21 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 118.467 -1.293 . . . . 0.0 108.632 -174.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -91.32 136.4 9.29 Favored 'Cis proline' 0 C--N 1.345 0.367 0 C-N-CA 123.078 -1.634 . . . . 0.0 110.434 18.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' THR . . . . . 0.531 ' H ' HG22 ' A' ' 478' ' ' ILE . 29.1 p -107.67 166.55 10.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.695 1.236 . . . . 0.0 109.683 -175.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -157.31 120.1 3.96 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.048 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -159.67 142.73 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 118.072 -1.451 . . . . 0.0 110.247 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 47.4 t -113.73 130.76 56.38 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.617 -174.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -135.69 120.07 17.98 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' VAL . . . . . . . . . . . . . 2.5 p -94.44 135.08 29.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.077 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -131.46 171.13 13.76 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 123.37 1.557 . . . . 0.0 111.795 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 57.8 p -146.36 -171.15 3.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 113.18 -1.827 . . . . 0.0 106.191 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.5 p -126.43 165.0 19.89 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 119.136 -1.025 . . . . 0.0 109.829 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ALA . . . . . . . . . . . . . . . -92.04 -17.78 24.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.806 0.812 . . . . 0.0 109.303 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -148.71 134.8 19.2 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 56.8 91.99 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.851 0.834 . . . . 0.0 109.371 -174.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ASN . . . . . 0.445 ' H ' ' HA ' ' A' ' 466' ' ' PRO . 21.2 t-20 -83.81 -68.61 0.7 Allowed 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.984 -173.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -97.26 71.39 2.38 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . 0.545 ' HA ' ' H ' ' A' ' 462' ' ' ILE . 1.9 t -159.32 -24.25 0.07 Allowed 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.217 -1.393 . . . . 0.0 110.011 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ALA . . . . . . . . . . . . . . . -167.29 114.68 0.78 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 117.963 -1.495 . . . . 0.0 111.989 172.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.92 142.43 17.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 102.099 -3.297 . . . . 0.0 102.099 171.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' THR . . . . . . . . . . . . . 13.9 m -95.06 127.84 41.43 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.261 -1.376 . . . . 0.0 108.287 174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ILE . . . . . . . . . . . . . 25.6 mm -106.91 53.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 122.841 1.305 . . . . 0.0 107.667 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -92.76 95.8 9.77 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 102.098 -3.297 . . . . 0.0 102.098 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 400' ' ' GLY . 1.5 t -85.4 130.02 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 -171.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.6 tp -110.98 110.51 21.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 123.091 1.425 . . . . 0.0 113.463 -172.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . 1.329 ' O ' ' HB3' ' A' ' 452' ' ' LYS . 62.8 tt0 -90.13 99.51 12.52 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 112.622 -2.081 . . . . 0.0 110.475 174.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -156.49 -134.48 1.8 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 119.125 -1.512 . . . . 0.0 110.567 174.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -103.48 -86.6 0.44 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.828 -0.807 . . . . 0.0 111.367 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -158.38 -103.85 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 117.986 -1.486 . . . . 0.0 113.235 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.28 -50.31 8.52 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 119.926 -1.733 . . . . 0.0 113.194 -172.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.01 108.49 2.23 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -83.06 86.92 6.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 123.743 1.735 . . . . 0.0 115.297 -172.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' ALA . . . . . . . . . . . . . . . -128.11 24.44 5.97 Favored 'General case' 0 CA--C 1.515 -0.381 1 N-CA-C 96.84 -5.244 . . . . 0.0 96.84 169.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . 0.266 48.3 m-20 -99.4 40.94 1.18 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 110.338 -3.119 . . . . 0.0 109.378 -173.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -101.05 50.28 0.87 Allowed 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.499 -1.28 . . . . 0.0 112.069 -172.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' LYS . . . . . 1.329 ' HB3' ' O ' ' A' ' 442' ' ' GLN . 59.1 tptt -75.47 128.98 36.53 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' SER . . . . . . . . . . . . . 50.4 m -73.05 124.39 25.42 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 118.33 -1.348 . . . . 0.0 111.831 -172.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.52 32.13 4.21 Favored 'General case' 0 N--CA 1.442 -0.858 1 N-CA-C 98.68 -4.563 . . . . 0.0 98.68 172.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . 130.59 178.78 15.62 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 118.011 -2.042 . . . . 0.0 117.407 172.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -175.41 77.19 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 112.645 -1.778 . . . . 0.0 106.399 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -135.63 -171.94 2.97 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -153.81 132.34 12.13 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.198 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' LEU . . . . . . . . . . . . . 5.6 tt -86.98 101.61 13.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -112.46 152.63 28.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 122.725 1.25 . . . . 0.0 113.409 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 81.52 69.78 1.38 Allowed Glycine 0 C--N 1.324 -0.123 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.391 174.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . 0.545 ' H ' ' HA ' ' A' ' 434' ' ' SER . 2.3 mp -119.57 56.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 118.18 -1.408 . . . . 0.0 107.975 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 10.3 m120 64.33 162.44 0.12 Allowed Pre-proline 0 CA--C 1.558 1.276 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.39 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -85.18 105.12 0.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 O-C-N 118.086 -1.586 . . . . 0.0 110.099 -173.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -152.9 82.3 5.01 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 119.033 -1.067 . . . . 0.0 108.162 174.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.445 ' HA ' ' H ' ' A' ' 432' ' ' ASN . 47.0 Cg_endo -95.56 154.31 1.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 CA-C-N 121.341 1.515 . . . . 0.0 110.924 -159.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 58.3 106.48 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 69.61 133.87 0.07 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 119.596 -1.288 . . . . 0.0 114.154 173.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 54.6 mmm -138.94 -61.19 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 116.632 -1.651 . . . . 0.0 109.823 173.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -113.08 86.84 0.03 OUTLIER 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 126.257 3.27 . . . . 0.0 108.081 -5.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' GLN . . . . . 0.891 ' O ' ' HB2' ' A' ' 491' ' ' LYS . 90.1 mt-30 -130.31 59.13 1.65 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -172.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' ILE . . . . . 0.413 HG23 ' HA ' ' A' ' 490' ' ' ASP . 2.1 mt -117.17 98.59 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 172.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -81.97 132.61 35.26 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 118.733 -1.187 . . . . 0.0 108.921 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 57.4 t -120.79 114.36 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -174.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 138.48 48.17 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.007 -175.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -130.52 108.61 10.07 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.614 1.197 . . . . 0.0 108.191 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -111.46 121.07 44.23 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.991 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 420' ' ' THR . 9.2 tt -95.2 152.94 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 117.037 -1.865 . . . . 0.0 106.1 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -91.98 -177.2 4.64 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -84.6 -17.53 38.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.98 -174.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -84.27 -36.56 22.58 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.089 -1.045 . . . . 0.0 109.064 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . 125.84 71.61 0.19 Allowed Glycine 0 N--CA 1.467 0.719 0 C-N-CA 119.634 -1.269 . . . . 0.0 110.859 174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' ILE . . . . . . . . . . . . . 4.7 tp -149.72 128.75 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' LEU . . . . . . . . . . . . . 14.8 tp -84.45 102.37 12.75 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 118.653 -1.219 . . . . 0.0 107.924 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -87.1 83.45 7.45 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.91 -1.496 . . . . 0.0 108.559 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.49 124.94 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 122.312 1.053 . . . . 0.0 109.7 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 68.6 p -110.08 108.57 18.81 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.795 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 496' ' ' GLU . . . -76.86 104.96 7.64 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 173.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -101.82 124.03 46.76 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' ASP . . . . . 0.413 ' HA ' HG23 ' A' ' 472' ' ' ILE . 0.8 OUTLIER -101.21 146.73 27.13 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -174.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.891 ' HB2' ' O ' ' A' ' 471' ' ' GLN . 3.5 mmpt? -102.35 40.56 1.33 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.998 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -102.47 -43.39 5.66 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' SER . . . . . . . . . . . . . 70.9 m -155.4 13.77 0.37 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 118.626 -1.23 . . . . 0.0 107.883 173.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . 80.59 34.08 29.31 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 107.407 -2.277 . . . . 0.0 107.407 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.07 101.0 5.13 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 488' ' ' ALA . 9.4 pt-20 -122.92 162.76 21.63 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 118.719 -1.193 . . . . 0.0 112.242 -173.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -142.56 117.1 9.71 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -99.59 105.21 17.05 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.183 -1.007 . . . . 0.0 109.202 -176.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 5.2 pt -89.73 154.52 3.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 122.753 1.263 . . . . 0.0 108.883 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 17.9 p -128.31 85.97 2.4 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.7 tt -110.87 140.82 28.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.051 -172.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' LYS . . . . . . . . . . . . . 66.2 mttp -64.78 175.1 1.57 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.717 1.246 . . . . 0.0 111.858 -174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -164.14 33.82 0.08 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.618 -1.174 . . . . 0.0 107.841 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 46.5 t -70.51 144.52 51.33 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.956 -174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' SER . . . . . . . . . . . . . 98.0 p -81.04 -143.43 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.772 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . 91.02 54.29 2.05 Favored Glycine 0 N--CA 1.463 0.457 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.193 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.74 -162.27 1.22 Allowed 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.567 175.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' ASN . . . . . 0.567 ' O ' ' HB3' ' A' ' 511' ' ' GLU . 84.0 m-20 -131.4 165.63 23.06 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 123.395 1.569 . . . . 0.0 113.427 -173.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.64 -21.42 62.63 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 113.619 -1.628 . . . . 0.0 111.087 175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' ASP . . . . . 0.946 ' O ' ' HB2' ' A' ' 514' ' ' LYS . 5.2 p-10 -112.14 34.84 4.03 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 123.696 1.712 . . . . 0.0 107.599 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 508' ' ' ASN . 9.5 tp10 -94.74 -39.97 10.02 Favored 'General case' 0 N--CA 1.435 -1.187 1 N-CA-C 92.415 -6.883 . . . . 0.0 92.415 166.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.01 -66.7 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.355 0 CA-C-N 112.294 -2.23 . . . . 0.0 108.829 172.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' GLN . . . . . 0.429 ' C ' ' H ' ' A' ' 516' ' ' VAL . 43.7 tt0 -60.88 -20.27 61.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 118.246 -2.784 . . . . 0.0 115.5 176.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' LYS . . . . . 0.946 ' HB2' ' O ' ' A' ' 510' ' ' ASP . 88.6 tttt -76.37 -27.6 56.45 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 119.165 -2.209 . . . . 0.0 106.633 173.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' MET . . . . . 0.402 ' HB3' ' HB3' ' A' ' 519' ' ' ALA . 25.5 mtm -84.4 -3.78 58.52 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.386 172.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' VAL . . . . . 0.858 ' HA ' ' HB2' ' A' ' 520' ' ' GLU . 1.7 t -75.51 -35.69 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 171.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -71.28 -72.81 0.2 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 115.089 -2.644 . . . . 0.0 110.706 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -57.53 -50.22 73.81 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 118.904 -1.118 . . . . 0.0 110.344 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 515' ' ' MET . . . -99.45 -6.69 27.21 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 118.175 -1.41 . . . . 0.0 113.283 -171.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.858 ' HB2' ' HA ' ' A' ' 516' ' ' VAL . 22.3 tt0 -84.94 -31.07 23.81 Favored 'General case' 0 C--N 1.366 1.302 1 N-CA-C 99.873 -4.121 . . . . 0.0 99.873 -177.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.96 -29.99 66.15 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.119 173.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -74.66 -10.45 59.55 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 120.609 -1.307 . . . . 0.0 111.422 174.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -69.45 -6.36 29.81 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 120.446 -1.409 . . . . 0.0 111.883 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 527' ' ' ARG . 35.4 tt0 -75.65 -26.98 58.17 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.612 -1.305 . . . . 0.0 108.353 173.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -72.96 -32.13 65.03 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -71.83 -12.56 61.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 118.837 -1.145 . . . . 0.0 109.758 172.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 524' ' ' GLU . 79.7 ttt180 -71.66 -30.21 65.47 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.237 1.018 . . . . 0.0 108.578 173.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -67.18 -36.32 81.52 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' PHE . . . . . 0.536 ' O ' HG23 ' A' ' 533' ' ' VAL . 73.0 m-85 -78.73 -3.98 46.98 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 118.837 -1.145 . . . . 0.0 111.567 173.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.39 -19.47 28.06 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -76.94 -32.4 57.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 13.6 tp -69.92 -32.63 71.02 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.644 174.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 529' ' ' PHE . 41.1 t -63.89 -54.77 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 119.44 9.29 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 54.74 113.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 111.751 -2.477 . . . . 0.0 114.617 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' ARG . . . . . . . . . . . . . 6.6 ptm85 -160.36 -104.63 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.417 -1.719 . . . . 0.0 106.814 -175.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' ASN . . . . . . . . . . . . 0.252 0.1 OUTLIER 140.18 -178.15 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 O-C-N 125.299 1.625 . . . . 0.0 109.463 173.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 69.69 -95.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.716 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 84.8 38.24 9.64 Favored Glycine 0 C--N 1.318 -0.451 0 C-N-CA 118.642 -1.742 . . . . 0.0 111.502 174.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -73.71 112.52 9.89 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 174.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 78.48 -64.33 0.27 Allowed 'General case' 0 N--CA 1.485 1.283 0 O-C-N 124.22 0.95 . . . . 0.0 111.636 -174.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.03 146.1 53.97 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.491 -0.883 . . . . 0.0 109.312 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 2.5 tt -169.09 102.56 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -174.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -62.25 143.32 57.01 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.69 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 15.1 p -160.09 108.91 1.73 Allowed 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.828 -174.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 9.0 t -159.71 139.81 11.76 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 118.435 -1.306 . . . . 0.0 109.728 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -83.54 -175.28 5.74 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.144 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -159.87 112.1 2.07 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.05 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -162.14 74.98 0.44 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.637 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.33 169.6 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.149 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -86.3 -17.75 33.77 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.898 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 553' ' ' ALA . 51.8 mt-10 -81.62 157.77 24.58 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.898 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 552' ' ' GLU . . . . . . . . 0 C--O 1.27 2.155 0 CA-C-N 120.581 1.537 . . . . 0.0 110.98 179.995 . . . . . . . . 1 1 . 1 stop_ save_